DAVA Oncology is a company dedicated to facilitating successful cancer drug development within the pharmaceutical and biotechnology industries. Founded in 2007, the company aims to achieve its goal by offering innovative solutions and services. DAVA has three business units: DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovations, and ONE Oncology. These units work towards accelerating clinical trial research timelines through MD-to-MD focused trial education, hosting non-CME scientific exchange programs across more than fifteen solid tumor and hematologic malignancies, and creating custom and syndicated oncology education tools. DAVA Oncology, with its headquarters in the United States, caters to the Biotechnology, Pharmaceutical, and Marketing industries. Currently, there is no information available about the last investment or the investors.
There is no investment information
No recent news or press coverage available for DAVA Oncology.